CSPC Pharmaceutical (HKG:1093) obtained drug registration approval for its Lansoprazole Enteric-coated Capsules from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.
The product is indicated to treat gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, and anastomotic ulcer.
Orient International Enterprise (SHA:600278) directors approved 490 million yuan in outward investments in 2026, according to a Tuesday filing with the Shanghai bourse.The amount is 7 million yuan lower than the 2025 figure.Seven subsidiaries and the headquarters are approved to apply up to 440 million yuan, while the other subsidiaries will be approved to apply for the remaining 50 million yuan.
Kurita Water Industries (TYO:6370) declared a year-end dividend of 56 yen per share for the fiscal year ended March 31, matching earlier forecasts and higher than the 46 yen per share paid a year ago.The total dividend payment amounts to 6.15 billion yen, payable from retained earnings on June 26, according to a Tokyo bourse filing on Tuesday.For the fiscal year ending March 31, 2027, Kurita Water Industries expects a total dividend of 112 yen per share, consisting of an interim and year-end dividend of 56 yen each.
Xiaomi (HKG:1810) is launching a new share repurchase program effective June 2 to buy back up to HK$20 billion of class B shares over the next 12 months, according to a Tuesday Hong Kong bourse filing.The tech giant will subsequently cancel the repurchased shares.The buyback is subject to shareholder approval.